Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases

Welcome to BIOBADASER, the Spanish Biologics Register.

BIOBADASER collects actively information on relevant adverse events occurring during the long term treatment with biologic therapies. The objective of the register is to identify adverse events in daily practice conditions, to estimate the risk of adverse events, and to assess the survival of the biologics in the long term.

BIOBADASER is the result of a collaborative effort of the Spanish rheumatologists, the Research Unit of the Spanish Foundation for Rheumatology (FER), the Spanish Agency for Medicines and Medical Devices (AEMyPS) and the Spanish Society of Rheumatology (SER).

Sponsors

The pharmaceutical companies displayed below sponsor this register. To warranty the scientific independence of BIOBADASER, monetary contribution provided by each one of these supporting companies is equal, and lower than twice the amount granted by the SER and the AEMyPS, separately.